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AUTHOR’S VIEW
Compartmentalized DNA repair: Rif1 S-acylation links DNA double-strand break
repair to the nuclear membrane
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ABSTRACT
DNA double-strand breaks (DSBs) disrupt the structural integrity of chromosomes. Proper DSB repair
pathway choice is critical to avoid the type of gross chromosomal rearrangements that characterize
cancer cells. Recent findings reveal S-fatty acylation and membrane anchorage of Rap1-interacting factor
1 (Rif1) as a mechanism providing spatial control over DSB repair pathway choice.
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DNA double-strand breaks (DSBs) pose a direct threat to
chromosome stability and must be repaired in a timely man-
ner to avoid chromosomal translocations or loss. Cells have
two competing DSB repair pathways at their disposal: non-
homologous end-joining (NHEJ) and homologous recombi-
nation (HR).1 NHEJ is a DNA splicing mechanism that entails
DNA end-protection, end-bridging, alignment of DNA ends,
and ligation. The pathway is very effective but associated with
the risk of DNA sequence alterations at the repair joint and
even gross chromosomal aberrations by ligation of DNA ends
that did not originate from the same DSB. HR is a more
elaborate DSB repair pathway that uses an intact donor
DNA with sequence homology to the break site. In
a process called DNA end-resection, nucleases first generate
3′-single-stranded DNA. This is followed by homology search
and strand invasion of a suitable donor duplex, where the
invading 3′-single-strand initiates DNA repair synthesis.
Resolution of the joint molecule, consisting of the broken
molecule and the intact donor, ultimately restores the DSB
site to its original sequence. DSB repair by HR is considered
an error-free process, although non-allelic recombination can
result in chromosome rearrangements. It is perhaps not sur-
prising then that DSB repair pathway choice is highly regu-
lated to ensure faithful repair at chromosome breaks. NHEJ or
HR are used in a context-specific manner dependent on cell-
cycle stage, chromatin status, and subnuclear location of
DSBs.1,2
At the nexus of DSB repair pathway choice lies the antag-
onism between DNA end-protection, which preserves the
option of NHEJ, and DNA end-resection, which commits to
HR repair.1 In mammalian cells, DNA end-resection is pro-
moted by breast cancer type 1 susceptibility protein (BRCA1)
in conjunction with C-terminal binding protein (CtBP)-
interacting protein (known as CtIP). BRCA1-CtIP interac-
tions are cell-cycle-regulated and promoted in the S and G2
phases, ensuring that end-resection and HR operate at a time
when sister chromatids in close proximity can serve as homo-
logous DSB repair templates for one another. DNA end-
resection is counteracted along an axis defined by tumor
protein 53 (TP53)-binding protein 1 (TP53BP1, better
known as 53BP1) and Rap1-interacting factor 1 (RIF1).
Thus, 53BP1-RIF1 limit the formation of microscopically
visible BRCA1 foci at DSBs, and, with downstream effectors
that constitute the so-called shieldin complex, preserve DSB
ends for NHEJ.3 Much of the current interest in the molecular
underpinnings of DSB repair pathway choice arises from the
success of poly (ADP-ribose) polymerase inhibitors (PARPi)
in cancer therapy.4 BRCA1-deficent tumors are exquisitely
sensitive to PARPi, reflecting an accumulation of DNA lesions
that would normally be repaired by HR. However, acquired
PARPi resistance occurs in the clinic. In BRCA1-defective
cells, PARPi resistance is conferred by mutations affecting
end-protection along the 53BP1-RIF1 axis, which restores
DNA end-resection and DSB repair by HR. A detailed under-
standing of these pathways is therefore of biomedical
importance.
53BP1 and RIF1 are recruited to DSBs through interactions
between 53BP1 and DNA damage-induced histone modifica-
tions around chromosome breaks. RIF1’s mode of action
relates to its ability to bind shieldin, providing a bridge
between 53BP1 and downstream effector proteins that physi-
cally interact with DNA ends to attenuate end-resection.3
Crystal structure analysis of the conserved N-terminal domain
of Rif1 from Saccharomyces cerevisiae has revealed an elon-
gated, all-α-helical fold resembling the shape of a shepherd’s
crook.5 The “hook”, located at its N-terminal tip, contains
a high-affinity DNA-binding site that is required for Rif1 to
mediate NHEJ, and also to fulfill a yeast-specific role in
telomere length control.5 Thus, in budding yeast, direct
engagement with DNA ends enables Rif1 to function in
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distinct biological processes by gating access of end-
processing factors including telomerase and the end-
resection machinery.6
Recently, we found that Rif1-mediated NHEJ not only
depends on Rif1’s DNA-binding activity, but surprisingly,
also its posttranslational S-fatty acylation.7 Rif1 S-acylation is
mediated by protein fatty acyltransferase 4 (Pfa4), a member
of the conserved DHHC family of palmitoyl acyltransferases,
but the functional significance of this post-translational mod-
ification had remained unclear.8 Palmitoylation, the addition
of 16-carbon fatty acid moieties to cysteine residues, is the
most common type of protein S-acylation with hundreds of
confirmed and putative protein targets.9 The increased hydro-
phobicity of S-acylated proteins promotes protein–membrane
interactions and impacts protein trafficking, compartmentali-
zation, stability, and function. A well-characterized example is
provided by the HRas and KRas GTPases whose palmitoyla-
tion is required for plasma membrane localization and effec-
tive signal transduction. Very little is currently known about
the importance of S-acylation of nuclear proteins and the
functional role of S-acylation-mediated inner nuclear mem-
brane interactions. Interestingly, protein S-acylation has not
previously been implicated in DNA repair reactions.
Systematic mutation of surface-exposed cysteine residues
to alanine identified Rif1 cysteine residues 466 and 473 (C466
and C473) as alternative S-acylation sites required for the
accumulation of Rif1 at endonuclease-induced DSBs, the
attenuation of DNA end-resection, and efficient DSB repair
by NHEJ.7 Using a method we termed acyl-carbamidomethyl
exchange (ACE) for the replacement of S-fatty modifications
with a chemical moiety more amenable to detection by mass
spectrometry, we verified S-acylation of C466 and C473
in vivo. C466/C473 S-acylation promoted Rif1-membrane
interactions and proved essential for the formation of micro-
scopically visible Rif1 foci in response to DSBs induced by
ionizing radiation or radiomimetic drug Zeocin. These DNA
damage-induced Rif1 foci located exclusively to the nuclear
periphery, consistent with enhanced membrane interactions
of Rif1 through S-fatty acylation. In contrast to Rif1 foci, HR
repair foci – marked by the recombinase Rad52 (encoded by
radiation-sensitive gene RAD52) – are usually observed at
luminal positions, away from the inner nuclear membrane.
These findings are consistent with an element of spatial con-
trol in DSB repair pathway choice, where S-acylation-
mediated residency of Rif1 at the inner nuclear membrane
establishes a subnuclear compartment geared towards NHEJ
(Figure 1).7
The compartmentalization of DSB repair raises interesting
possibilities of designating repair pathway choices through
nuclear positioning of chromosomal regions. Rif1
S-acylation would conceivably bias DSB repair within nuclear
envelope-associated heterochromatin or near telomeres
towards NHEJ, which could protect from non-allelic recom-
bination within repetitive DNA sequences. It is also interest-
ing to consider that the ability to effectively tether DSB ends
to the inner nuclear membrane might have a direct impact on
the efficiency of NHEJ by assisting the coordination of DNA
ends for ligation. In a thought-provoking parallel to our
findings in yeast, NHEJ is favored within nuclear lamina-
associated chromatin in human cells.10 It is currently not
known whether these observations relate to inner nuclear
membrane interactions of human RIF1. Going forward, it
will be important to determine the S-acylation status of mam-
malian RIF1, and to address the possibility and potential
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Figure 1. Compartmentalized DNA double-strand break (DSB) repair pathway choice mediated by S-acylated Rap1-interacting factor 1 (Rif1). (a) Saccharomyces
cerevisiae Rif1 forms nuclear-peripheral foci in response to DSB-inducing agents. Z-projected confocal microscopy image shows the nuclear envelope labeled by
nuclear pore protein 49 (Nup49) fused to a red fluorescent protein tag (Ruby2). A version of Rif1 that is proficient for DSB repair but devoid of telomere interaction
motifs is expressed as fusion with a green fluorescent protein tag (GFP).7 (b) Rif1 foci are strongly biased towards the nuclear periphery. This indicates an
accumulation of Rif1 at DSBs within chromosomal regions attached to or near the inner nuclear membrane, and its absence from more luminal DSBs. (c) Membrane
anchorage of Rif1 by protein fatty acyltransferase 4 (Pfa4)-dependent S-acylation of cysteine residues 466/473 (indicated as a zig-zag line). High local concentration of
Rif1 at the inner nuclear membrane sets up a nuclear-peripheral zone in which DNA end-resection and homologous recombination (HR) is attenuated, favoring DSB
repair by non-homologous end-joining (NHEJ).
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biomedical implications of RIF1 promoting DSB repair path-
way choice at the nuclear periphery in human cells.
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